Preclinical efficacy of combined MEK and Src inhibition: MEK inhibitor reverses resistance to Src inhibitor therapy in ovarian cancer cells Conference

Simpkins, Fiona, Azzam, Diana, Slingerland, Joyce M. (2013). Preclinical efficacy of combined MEK and Src inhibition: MEK inhibitor reverses resistance to Src inhibitor therapy in ovarian cancer cells . CLINICAL CANCER RESEARCH, 19 10.1158/1078-0432.OVCA13-B50

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

volume

  • 19